These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1157005
1. Interrupted vs. continued maintenance therapy in childhood acute leukemia. Lonsdale D, Gehan EA, Fernbach DJ, Sullivan MP, Lane DM, Ragab AH. Cancer; 1975 Aug; 36(2):341-52. PubMed ID: 1157005 [Abstract] [Full Text] [Related]
2. Long-term results of reinforcement therapy in children with acute leukemia. Fernbach DJ, George SL, Sutow WW, Ragab AH, Lane DM, Haggard ME, Lonsdale D. Cancer; 1975 Nov; 36(5):1552-9. PubMed ID: 1192347 [Abstract] [Full Text] [Related]
3. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Schmiegelow K, Heyman M, Kristinsson J, Mogensen UB, Rosthøj S, Vettenranta K, Wesenberg F, Saarinen-Pihkala U, Nordic Society of Paediatric Haematology and Oncology (NOPHO). J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786 [Abstract] [Full Text] [Related]
4. 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia. Schmiegelow K, Bretton-Meyer U. Leukemia; 2001 Jan; 15(1):74-9. PubMed ID: 11243403 [Abstract] [Full Text] [Related]
5. Effects of continuous or discontinuous maintenance therapy on subsequent remission maintenance in childhood leukemia. Lane DM, George SL, Komp D, Lonsdale D, Pullen J, Ragab A, Starling KA. Cancer; 1977 Nov; 40(5):2005-9. PubMed ID: 336174 [Abstract] [Full Text] [Related]
7. Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia. Eppinger-Helft M, Pavlovsky S, Suarez A, Muriel FS, Hidalgo G, Pavlovsky A, Vilaseca G. Cancer; 1975 Feb; 35(2):347-53. PubMed ID: 1053936 [Abstract] [Full Text] [Related]
8. Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia. Berry DH, Pullen J, George S, Vietti TJ, Sullivan MP, Fernbach D. Cancer; 1975 Jul; 36(1):98-102. PubMed ID: 1203854 [Abstract] [Full Text] [Related]
14. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC. Hayat M, Jehn U, Willemze R, Haanen C, Zittoun R, Monconduit M, Lowenberg B, Stryckmans P, Peetermans M, De Cataldo F. Cancer; 1986 Aug 01; 58(3):617-23. PubMed ID: 3524789 [Abstract] [Full Text] [Related]
15. Induction of remission in childhood leukemia with vincristine and 6-mercaptopurine and methotrexate. Administration in sequence after prednisone. Sitarz AL, Brubaker C, Hartman J, Leiken S, Murphy ML, Wolff JA, Perrin E. Cancer; 1968 May 01; 21(5):920-5. PubMed ID: 5239542 [No Abstract] [Full Text] [Related]
16. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. Sackmann Muriel F, Svarch E, Pavlovsky S, Bustelo P, Giuntoli J, Vergara B, Garay G, Eppinger-Helft M, Kvicala R, Dibar E. Cancer Treat Rep; 1984 Apr 01; 68(4):581-6. PubMed ID: 6370428 [Abstract] [Full Text] [Related]